Analyze Diet
Frontiers in veterinary science2021; 8; 714800; doi: 10.3389/fvets.2021.714800

Postoperative Ileus: Comparative Pathophysiology and Future Therapies.

Abstract: Postoperative ileus (POI), a decrease in gastrointestinal motility after surgery, is an important problem facing human and veterinary patients. 37.5% of horses that develop POI following small intestinal (SI) resection will not survive to discharge. The two major components of POI pathophysiology are a neurogenic phase which is then propagated by an inflammatory phase. Perioperative care has been implicated, namely the use of opioid therapy, inappropriate fluid therapy and electrolyte imbalances. Current therapy for POI variably includes an early return to feeding to induce physiological motility, reducing the inflammatory response with agents such as non-steroidal anti-inflammatory drugs (NSAIDs), and use of prokinetic therapy such as lidocaine. However, optimal management of POI remains controversial. Further understanding of the roles of the gastrointestinal microbiota, intestinal barrier function, the post-surgical inflammatory response, as well as enteric glial cells, a component of the enteric nervous system, in modulating postoperative gastrointestinal motility and the pathogenesis of POI may provide future targets for prevention and/or therapy of POI.
Publication Date: 2021-09-13 PubMed ID: 34589533PubMed Central: PMC8473635DOI: 10.3389/fvets.2021.714800Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article explores postoperative ileus (POI), a condition characterized by reduced gastrointestinal movement after surgery. The study also maps out future therapies for this condition, while considering the roles of the gastrointestinal microbiota, inflammatory responses, and the function of the intestinal barrier.

Understanding Postoperative Ileus (POI)

  • Postoperative ileus (POI) is a condition characterized by a reduction or halt in gastrointestinal motility following surgery. This condition often has dire consequences for both human and veterinary patients, particularly horses where approximately 37.5% didn’t survive to discharge after developing POI following small intestinal resection.

Pathophysiology of POI

  • The study goes on to describe the two main components of POI pathophysiology, which include a neurogenic phase followed by an inflammatory phase.
  • Both these phases are further affected by perioperative care, specifically the use of opioid therapy, inappropriate fluid therapy and electrolyte imbalances.

Current POI Management and Therapy

  • Management and treatment of POI currently involve efforts to ensure early return to feeding in order to induce physiological motility.
  • Another aspect of intervention is the reduction of the inflammatory response through the administration of non-steroidal anti-inflammatory drugs (NSAIDs).
  • The use of prokinetic therapy, such as lidocaine, is another concurrent strategy. However, the best methods of managing POI remain a controversial topic due to varying results.

Future Therapies

  • Future therapies will consider a more inclusive understanding of the roles of the gastrointestinal microbiota, intestinal barrier function, and enteric glial cells, which are a component of the enteric nervous system.
  • Understanding these factors would provide a more comprehensive understanding of how gastrointestinal motility can be modulated post-surgery and how the pathogenesis of POI can be influenced.
  • This could ultimately lead to more effective prevention and treatment methods of POI in both human and veterinary medicine.

Cite This Article

APA
Hellstrom EA, Ziegler AL, Blikslager AT. (2021). Postoperative Ileus: Comparative Pathophysiology and Future Therapies. Front Vet Sci, 8, 714800. https://doi.org/10.3389/fvets.2021.714800

Publication

ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 8
Pages: 714800

Researcher Affiliations

Hellstrom, Emily A
  • Department of Clinical Sciences, North Carolina State University, Raleigh, NC, United States.
Ziegler, Amanda L
  • Department of Clinical Sciences, North Carolina State University, Raleigh, NC, United States.
Blikslager, Anthony T
  • Department of Clinical Sciences, North Carolina State University, Raleigh, NC, United States.

Grant Funding

  • P30 DK034987 / NIDDK NIH HHS
  • R01 HD095876 / NICHD NIH HHS

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 100 references
  1. Livingston EH, Passaro EP Jr. POI. Dig Dis Sci. (1990) 35:121–32. 10.1007/BF01537233
    doi: 10.1007/BF01537233pubmed: 2403907google scholar: lookup
  2. Lisowski ZM, Pirie RS, Blikslager AT, Lefebvre D, Hume DA, Hudson NPH. An update on equine post-operative ileus: definitions, pathophysiology and management. Equine Vet J (2018) 50:292–303.
    doi: 10.1111/evj.12801pubmed: 29281117google scholar: lookup
  3. Mazzotta E, Villalobos-Hernandez EC, Fiorda-Diaz J, Harzman A, Christofi FL. Postoperative ileus and postoperative gastrointestinal tract dysfunction: pathogenic mechanisms and novel treatment strategies beyond colorectal enhanced recovery after surgery protocols. Front Pharmacol (2020) 11:583422.
    doi: 10.3389/fphar.2020.583422pmc: PMC7774512pubmed: 33390950google scholar: lookup
  4. Hedrick TL, McEvoy MD, Mythen MMG, Bergamaschi R, Gupta R, Holubar SD. American society for enhanced recovery and perioperative quality initiative joint consensus statement on postoperative gastrointestinal dysfunction within an enhanced recovery pathway for elective colorectal surgery. Anesth Analg (2018) 126:1896–907.
    doi: 10.1213/ANE.0000000000002742pubmed: 29293183google scholar: lookup
  5. Merritt AM, Blikslager AT. Post operative ileus: to be or not to be?. Equine Vet J (2008) 40:295–6.
    doi: 10.2746/042516408X302537pubmed: 18672434google scholar: lookup
  6. Vather R, Trivedi S, Bissett I. Defining POI: results of a systematic review and global survey. J Gastrointestinal Surg (2013) 17:962–72.
    doi: 10.1007/s11605-013-2148-ypubmed: 23377782google scholar: lookup
  7. Venara A, Neunlist M, Slim K, Barbieux J, Colas PA, Hamy A. POI: pathophysiology, incidence, and prevention. J Vic Surg (2016) 153:439–46.
  8. Goldstein JL, Matuszewski KA, Delaney C, Senagore A, Chiao EF, Shah M. Inpatient economic burden of POI associated with abdominal surgery in the United States. Pharm Ther (2007) 32:82–90.
  9. Kronberg U, Kiran RP, Soliman MSM, Hammel JP, Galway U, Coffey JC. A characterization of factors determining POI after laparoscopic colectomy enables the generation of a novel predictive score. Ann Surg (2011) 253:78–81.
    doi: 10.1097/SLA.0b013e3181fcb83epubmed: 21233608google scholar: lookup
  10. Millan M, Biondo S, Fraccalvieri D, Frago R, Golda T, Kreisler E. Risk factors for prolonged POI after colorectal cancer surgery. World J Surg (2012) 36:179–85.
    doi: 10.1007/s00268-011-1339-5pubmed: 22083434google scholar: lookup
  11. Artinyan A, Nunoo-Mensah JW, Balasubramaniam S, Gauderman J, Essani R, Gonzalez-Ruiz C. Prolonged POI: definition, risk factors, predictors after surgery. World J Surg (2008) 32:1495–500.
    doi: 10.1007/s00268-008-9491-2pubmed: 18305994google scholar: lookup
  12. Vather R, Bisset IP. Risk factors for the development of prolonged post-operative ileus following elective colorectal surgery. Int J Colorectal Dis (2013) 28:1385–91.
    doi: 10.1007/s00384-013-1704-ypubmed: 23689489google scholar: lookup
  13. Chapuis PH, Bokey L, Keshava A, Rickard MJ, Stewart P, Young CJ. Risk factors for prolonged ileus after resection of colorectal cancer: an observational study of 2400 consecutive patients. Ann Surg (2013) 257:909–15.
    doi: 10.1097/SLA.0b013e318268a693pubmed: 23579542google scholar: lookup
  14. Morton AJ, Blikslager AT. Surgical and postoperative factors influencing short-term survival of horses following small intestinal resection: 92 cases (1994-2001). Equine Vet J (2002) 34:450–4.
    doi: 10.2746/042516402776117700pubmed: 12358046google scholar: lookup
  15. Curtis L, Burford JH, England GCW, Freeman SL. Risk factors for acute abdominal pain (colic) in the adult horse: a scoping review of risk factors, and a systematic review of the effect of management-related changes. PLoS ONE (2019) 14:e0219307.
  16. Kaneene JB, Miller R, Ross WA, Gallagher K, Marteniuk J, Rook J. Risk factors for colic in the Michigan (USA) equine population. Prev Vet Med (1997) 30:23–36.
    doi: 10.1016/S0167-5877(96)01102-6pubmed: 9234409google scholar: lookup
  17. Tinker MK, White NA, Lessard P, Thatcher CD, Pelzer KD, Davis B. Prospective study of equine colic incidence and mortality. Equine Vet J (1997) 29:448–53.
  18. Proudman CJ. A two-year, prospective survey of equine colic in general practice. Equine Vet J (1992) 24:90–93.
  19. Hudson JM, Cohen ND, Gibbs PG, Thompson JA. Feeding practices associated with colic in horses. J Am Vet Med Ass (2001) 219:1419–25.
    doi: 10.2460/javma.2001.219.1419pubmed: 11724182google scholar: lookup
  20. Mair TS. BEVA evidence-based medicine colic survey. In: Abeyasekere LAFJ, editor. Proceedings British Equine Veterinary Association Congress. Newmarket, ON: Barr Equine Veterinary Journal Ltd; (2004). p. 58–59.
  21. Archer DC, Proudman CJ. Epidemiological clues to preventing colic. Vet J (2006) 172:29–39.
    doi: 10.1016/j.tvjl.2005.04.002pubmed: 15939639google scholar: lookup
  22. Curtis L, Burford JH, Thomas JS, Curran ML, Bayes TC, England GC, Freeman SL. Prospective study of the primary evaluation of 1016 horses with clinical signs of abdominal pain by veterinary practitioners, and the differentiation of critical and non-critical cases. Acta Vet Scand (2015) 57:69.
    doi: 10.1186/s13028-015-0160-9pmc: PMC4596518pubmed: 26444675google scholar: lookup
  23. Freeman DE. Fifty years of colic surgery. Equine Vet J (2018) 50:423–35.
    doi: 10.1111/evj.12817pubmed: 29405434google scholar: lookup
  24. Vather R, O'Grady G, Bissett IP, Dinning PG. POI: mechanisms and future directions for research. Clin Exp Pharmacol Physiol (2014) 41:358–70.
    doi: 10.1111/1440-1681.12220pubmed: 24754527google scholar: lookup
  25. Boeckxstaens GE, Hirsch DP, Kodde A, Moojen TM, Blackshaw A, Tytgat GN. Activation of an adrenergic and vagally-mediated NANC pathway in surgery-induced fundic relaxation in the rat. Neurogastroenterol Mot (1999) 11:467–74.
  26. Holzer P, Lippe IT, Amann R. Participation of capsaicin-sensitive afferent neurons in gastric motor inhibition caused by laparotomy and intraperitoneal acid. Neuroscience (1992) 48:715–22.
    doi: 10.1016/0306-4522(92)90414-Wpubmed: 1603337google scholar: lookup
  27. Kahokeher A, Sammour T, Srinivasa S, Hill AG. Metabolic response to abdominal surgery: the 2-wound model. Surgery (2011) 149:301–4.
    doi: 10.1016/j.surg.2010.10.020pubmed: 21145570google scholar: lookup
  28. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature (2001) 413:203–10.
    doi: 10.1038/35093019pubmed: 11557989google scholar: lookup
  29. Fukuda H, Tsuchida D, Koda K, Miyazaki M, Pappas TN, Takahashi T. Inhibition of sympathetic pathways restores POI in the upper and lower gastrointestinal tract. J Gastroenterol Hepatol (2007) 22:1293–9.
  30. Lefebvre RA, Smits GJ, Timmermans JP. Study of NO and VIP as non-adrenergic non-cholinergic neurotransmitters in the pig gastric fundus. Br J Pharmacol (1995) 116:2017–26.
  31. DeWinter BY, Boeckxstaens GE, DeMan JG, Moreels TG, Herman AG, Pelckmans PA. Effect of adrenergic and nitrergic blockade on experimental ileus in rats. Br J Pharmacol (1997) 120:464–8.
    doi: 10.1038/sj.bjp.0700913pmc: PMC1564477pubmed: 9031750google scholar: lookup
  32. Bayliss WM, Starling EH. The movements and innervation of the small intestine. J Physiol (1899) 24:99–143.
  33. Carli F, Trudel JL, Belliveau P. The effect of intraoperative thoracic epidural anesthesia and postoperative analgesia on bowel function after colorectal surgery: a prospective, randomized trial. Dis Colon Rectum (2001) 44:1083–9.
    doi: 10.1007/BF02234626pubmed: 11535845google scholar: lookup
  34. Scheinin B, Asantila R, Orko R. The effect of bupivacaine and morphine on pain and bowel function after colonic surgery. Acta Anaesthesiol Scan (2008) 31:161–4.
  35. Ahn H, Bronge A, Johansson K, Ygge H, Lindhagen J. Effect of continuous postoperative epidural analgesia on intestinal motility. Br J Surg (2005) 75:1176–8.
    doi: 10.1002/bjs.1800751210pubmed: 3233467google scholar: lookup
  36. Liu SS, Carpenter RL, Mackey DC, Thirlby RC, Rupp SM, Shine TS. Effects of perioperative analgesic technique on rate of recovery after colon surgery. Anesthesiology (1995) 83:757–65.
  37. Freeman DE. Is there still a place for lidocaine in the (postoperative) management of colics?. Vet Clin North Am Equine Pract (2019) 35:275–88.
    doi: 10.1016/j.cveq.2019.03.003pubmed: 31076222google scholar: lookup
  38. Farro G, Gomez-Pinilla PJ, Di Giovangiulio M, Stakenborg N, Auteri M, Thijs T. Smooth muscle and neural dysfunction contribute to different phases of murine POI. Neurogastroenterol Motil (2016) 28:934–47.
    doi: 10.1111/nmo.12796pubmed: 26891411google scholar: lookup
  39. Narayan P, Singh VK, Agarwal SS, Tandon R, Haq W, Raghubir R. Immunomodulation by opioid peptidomimetic compound. Neuroimmunomodulation (2001) 9:134–40.
    doi: 10.1159/000049017pubmed: 11752886google scholar: lookup
  40. Ferraz AA, Wanderley GJ, Santos MA Jr, Mathias CA, Araujo JG Jr, Ferraz EM. Effects of propranolol on human POI. Dig Surg (2001) 18:305–10.
    doi: 10.1159/000050157pubmed: 11528141google scholar: lookup
  41. Kalff JC, Türler A, Schwarz NT, Schraut WH, Lee KK, Tweardy DJ. Intra-abdominal activation of a local inflammatory response within the human muscularis externa during laparotomy. Ann Surg (2003) 237:301.
  42. The FO Bennink RJ, Ankum WM, Buist MR, Busch OR, Gouma DJ. Intestinal handling induced mast cell activation and inflammation in human POI. Gut (2008) 57:33–40.
    doi: 10.1136/gut.2007.120238pubmed: 17591620google scholar: lookup
  43. Kalff JC, Schraut WH, Simmons RL, Bauer AJ. Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus. Ann Surg (1998) 228:652–63.
  44. Kalff JC, Carlos TM, Schraut WH, Billiar TR, Simmons RL, Baeur AJ. Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate POI. Gastroenterology (1999) 117:378–87.
    doi: 10.1053/gast.1999.0029900378pubmed: 10419919google scholar: lookup
  45. Schwarz NT, Kalff JC, Türler A, Engel BM, Watkins SC, Billiar TR. Prostanoid production via COX-2 as a causative mechanism of rodent POI. Gastroenterology (2001) 121:1354–71.
    doi: 10.1053/gast.2001.29605pubmed: 11729115google scholar: lookup
  46. Kapetanovic R, Fairbairn L, Beraldi D, Sester DP, Archibald AL, Tuggle CK. Pig bone marrow-derived macrophages resemble human macrophages in their response to bacterial lipopolysaccharide. J Immunol (2012) 188:3382–94.
    doi: 10.4049/jimmunol.1102649pubmed: 22393154google scholar: lookup
  47. Karagianni AE, Kapetanovic R, McGorum BC, Hume DA, Pirie SR. The equine alveolar macrophage: functional and phenotypic comparisons with peritoneal macrophages. Vet Immunol Immunopathol (2013) 155:219–28.
  48. Kalff JC, Eskandari MK, Hierholzer C, Schraut WH, Simmons RL, Baeur AJ. Biphasic response to gut manipulation and temporal correlation of cellular infiltrates and muscle dysfunction in rat. Surgery (1999) 126:498–509.
    doi: 10.1016/S0039-6060(99)70091-7pubmed: 10486602google scholar: lookup
  49. de Jonge WJ, The FO van der Coelen D, Bennink RJ, Reitsma PH, van Deventer SJ. Mast cell degranulation during abdominal surgery initiates POI in mice. Gastroenterology (2004) 127:535–45.
    doi: 10.1053/j.gastro.2004.04.017pubmed: 15300586google scholar: lookup
  50. Wehner S, Behrendt FF, Lyutenski BN, Lysson M, Bauer AJ, Hirner A. Inhibition of macrophage function prevents intestinal inflammation and POI in rodents. Gut (2007) 56:176–85.
    doi: 10.1136/gut.2005.089615pmc: PMC1856749pubmed: 16809419google scholar: lookup
  51. The FO de Jonge WJ, Bennink RJ, van den Wijngaard RM, Boeckxstaens GE. The ICAM-1 antisense oligonucleotide ISIS-3082 prevents the development of POI in mice. Br J Pharmacol (2005) 146:252–8.
    doi: 10.1038/sj.bjp.0706303pmc: PMC1576259pubmed: 15997238google scholar: lookup
  52. De Jonge WJ, Van Den Wijngaard RM, The FO Ter Beek ML, Bennink RJ, Tytgat GNJ. POI is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in mice. Gastroenterol (2003) 125:1137–47.
    doi: 10.1016/S0016-5085(03)01197-1pubmed: 14517797google scholar: lookup
  53. Kreiss C, Birder LA, Kiss S, VanBibber MM, Baeur AJ. COX-2 dependent inflammation increases spinal Fos expression during rodent POI. Gut (2003) 52:527–34.
    doi: 10.1136/gut.52.4.527pmc: PMC1773580pubmed: 12631664google scholar: lookup
  54. Boeckxstaens GE, De Jonge WJ. Neuroimmune mechanisms in POI. Gut (2009) 58:1300–11.
    doi: 10.1136/gut.2008.169250pubmed: 19671558google scholar: lookup
  55. Kalff JC, Schraut WH, Billiar TR, Simmons RL, Bauer AJ. Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology (2000) 118:316–27.
    doi: 10.1016/S0016-5085(00)70214-9pubmed: 10648460google scholar: lookup
  56. Holte K, Sharrock N, Kehle H. Pathophysiology and clinical implications of perioperative fluid excess. Br J Anaesth (2002) 89:622–32.
    doi: 10.1093/bja/aef220pubmed: 12393365google scholar: lookup
  57. Engel DR, Koscielny A, Wehner S, Maurer J, Schiwon M, Franken L. T helper type 1 memory cells disseminate POI over the entire intestinal tract. Nat Med (2010) 16:1407–13.
    doi: 10.1038/nm.2255pubmed: 21113155google scholar: lookup
  58. Stoffels B, Schmidt J, Nakao A, Nazir A, Chanthaphavong RS. Role of interleukin 10 in murine postoperative ileus. Gut (2009) 58:648–60.
    doi: 10.1136/gut.2008.153288pubmed: 19359433google scholar: lookup
  59. Farro G, Stakenborg M, Gomez-Pinilla PJ, Labeeuw E, Goverse G, Giovangiulio MD. CCR2-dependent monocyte-derived macrophages resolve inflammation and restore gut motility in POI. Gut (2017) 66:2098–109.
    doi: 10.1136/gutjnl-2016-313144pubmed: 28615302google scholar: lookup
  60. Van Bree SHW, Gomez-Pinilla PJ, van de Bovenkamp FS, Di Giovangiulio M, Farro G, Nemethova A. Inhibition of spleen tyrosine kinase as a treatment of POI. Gut (2013) 62:1581–90.
    doi: 10.1136/gutjnl-2012-302615pubmed: 23242119google scholar: lookup
  61. De Jonge WJ, van der Zanden EP. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol (2005) 6:844–51.
    doi: 10.1038/ni1229pubmed: 16025117google scholar: lookup
  62. The FO Buist MR, Lei A, Bennink RJ, Hofland J, van den Wijngaard RM. The role of mast cell stabilization in treatment of POI: a pilot study. Am J Gastroenterol (2009) 104:2257–66.
    doi: 10.1038/ajg.2009.268pubmed: 19491822google scholar: lookup
  63. Hopster-Iversen CC, Hopster K, Staszyk C, Rohn K, Freeman DE, Rotting. Effects of experimental mechanical manipulations on local inflammation in the jejunum of horses. Am J Vet Res (2014) 75:385–91.
    doi: 10.2460/ajvr.75.4.385pubmed: 24669925google scholar: lookup
  64. van Bree SH, Nemethova A, van Bovenkamp FS, Gomez-Pinilla P, Elbers L, DiGiovangiulio M. Novel method for studying POI in mice. Int J Physiol, Pathophysiol Pharmacol (2012) 4:219–27.
    pmc: PMC3544220pubmed: 23320135
  65. Türler A, Schnurr C, Nakao A, Tögel S, Moore BA, Murase N. Endogenous endotoxin participates in causing a panenteric inflammatory ileus after colonic surgery. Ann Surg (2007) 245:734.
  66. Echtenacher B, Männel DN, Hültner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature (1996) 381:75–7.
    doi: 10.1038/381075a0pubmed: 8609992google scholar: lookup
  67. Bauer AJ, Boeckxstaens GE. Mechanisms of POI. Neurogastroenterol Motil (2004) 16(Suppl. 2):54–60.
  68. Vaughan-Shaw P, Fecher I, Harris S, Knight J. A meta-analysis of the effectiveness of the opioid receptor antagonist alvimopan in reducing hospital length of stay and time to GI recovery in patients enrolled in a standardized accelerated recovery program after abdominal surgery. Dis Colon Rectum (2012) 55:611–20.
    doi: 10.1097/DCR.0b013e318249fc78pubmed: 22513441google scholar: lookup
  69. Lefebvre D, Hudson NP, Elce YA, Blikslager A, Divers TJ, Handel IG. Clinical features and management of equine post operative ileus (POI):survey of diplomates of the american colleges of veterinary internal medicine (ACVIM),veterinary surgeons (ACVS) and veterinary emergency and critical care (ACVECC). Equine Vet J (2016) 48:714–9.
    doi: 10.1111/evj.12520pubmed: 26502215google scholar: lookup
  70. Lefebvre D, Pirie RS, Handel IG, Tremaine WH, Hudson NP. Clinical features and management of equine post operative ileus: Survey of diplomates of the European colleges of equine internal medicine (ECEIM) and veterinary surgeons (ECVS). Equine Vet J (2016) 48:182–7.
    doi: 10.1111/evj.12355pubmed: 25256601google scholar: lookup
  71. Gustafsson UO, Hausel J, Thorell A, Ljungqvist O, Soop M, Nygren J. Adherence to the enhanced recovery after surgery protocol and outcomes after colorectal cancer surgery. Arch Surg (2011) 146:571–7.
    doi: 10.1001/archsurg.2010.309pubmed: 21242424google scholar: lookup
  72. Brandstrup B, Tonnesen H, Beier-Holgersen R, Hjortso E, Ording H, Lindorff-Larsen K. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg (2003) 238:641–8.
  73. Milne TGE, Jaunge R, O'Grady G, Bisset IP. Nonsteroidal anti-inflammatory drugs reduce the time to recovery of gut function after elective colorectal surgery: a systematic review and meta-analysis. Colorectal Dis (2018) 20:190–8.
    doi: 10.1111/codi.14268pubmed: 29781564google scholar: lookup
  74. Naylor RJ, Taylor AH, Knowles EJ, Wilford S, Linnenkohl W, Mair TS. Comparison of flunixin meglumine and meloxicam for post operative management of horses with strangulating small intestinal lesions. Equine Vet J (2014) 46:427–34.
    doi: 10.1111/evj.12224pubmed: 24372991google scholar: lookup
  75. Van Hoogmoed LM, Nieto JE, Snyder JR, Harmon FA. Survey of prokinetic use in horses with gastrointestinal injury. Vet Surg (2004) 33:279–85.
  76. Salem SE, Proudman CJ, Archer DC. Has intravenous lidocaine improved the outcome in horses following surgical management of small intestinal lesions in a UK hospital population?. BMC Vet Res (2016) 12:157.
    doi: 10.1186/s12917-016-0784-7pmc: PMC4962447pubmed: 27459996google scholar: lookup
  77. Helman CA. Chewing gum is as effective as food in stimulating cephalic phase gastric secretion. Am J Gastroenterol (1988) 83:640–2.
    pubmed: 3376919
  78. Freeman DE, Hammock P, Baker GJ, Goetz T, Foreman JH, Schaeffer DJ. Short- and long-term survival and prevalence of POI after small intestinal surgery in the horse. Equine Vet J (2000) 32(Suppl. 32):42–51.
  79. Wehner S, Straesser S, Vilz TO, Pantelis D, Sielecki T, de la Cruz VF. Inhibition of p38 mitogen-activated protein kinase pathway as prophylaxis of POI in mice. Gastroenterol (2009) 136:619–29.
    doi: 10.1053/j.gastro.2008.10.017pubmed: 19014943google scholar: lookup
  80. Vilz TO, Sommer N, Kahl P, Pantelis D, Kalff JC, Wehner S. Oral CPSI-2364 treatment prevents POI in swine without impairment of anastomotic healing. Cell Physiol Biochem (2013) 32:1362–73.
    doi: 10.1159/000356575pubmed: 24280834google scholar: lookup
  81. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature (2000) 405:458–62.
    doi: 10.1038/35013070pubmed: 10839541google scholar: lookup
  82. Matteoli G, Gomez-Pinilla PJ, Nemethova A, Di Giovangiulio M, Cailotto C, van Bree SH. A distinct vagal anti-inflammatory pathway modulates intestinal muscularis resident macrophages independent of the spleen. Gut (2014) 63:938–48.
    doi: 10.1136/gutjnl-2013-304676pubmed: 23929694google scholar: lookup
  83. The FO Boeckxstaens GE, Snoek SA, Cash JL, Bennink R, Larosa GJ. Activation of the cholinergic anti-inflammatory pathway ameliorates POI in mice. Gastroenterology (2007) 133:1219–28.
    doi: 10.1053/j.gastro.2007.07.022pubmed: 17919496google scholar: lookup
  84. Wolthuis AM, Stakenborg N, D'Hoore A, Boeckxstaens GE. The pig as a preclinical model for laparoscopic vagus nerve stimulation. Int J Colorectal Dis (2016) 31:211–5.
    doi: 10.1007/s00384-015-2435-zpubmed: 26546440google scholar: lookup
  85. Shogan BD, Smith DP, Christley S, Gilbert JA, Zaborina O, Alverdy JC. Intestinal anastomotic injury alters spatially defined microbiome composition and function. Microbiome (2014) 2:35.
    doi: 10.1186/2049-2618-2-35pmc: PMC4171717pubmed: 25250176google scholar: lookup
  86. Sommovilla J, Zhou Y, Sun RC, Choi PM, Diaz-Miron J, Shaikh NN. Small bowel resection induces long-term changes in the enteric microbiota of mice. J Gastrointest Surg (2015) 19:56–64; discussion 64.
    doi: 10.1007/s11605-014-2631-0pmc: PMC4576885pubmed: 25183407google scholar: lookup
  87. Liu Z, Qin H, Yang Z, Xia Y, Liu W, Yang J. Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery—a double-blind study. Aliment Pharmacol Ther (2011) 33:50–63.
  88. Sugawara G, Nagino M, Nishio H, Ebata T, Takagi K, Ashara T. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg (2006) 244:706–14.
  89. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature (2011) 469:543–7.
    doi: 10.1038/nature09646pubmed: 21270894google scholar: lookup
  90. Shin SY, Hussain Z, Lee YJ, Park H. An altered composition of fecal microbiota, organic acids, and the effect of probiotics in the guinea pig model of POI. Neurogastroenterol Motil (2020) 19:e13966.
    doi: 10.1111/nmo.13966pubmed: 32815235google scholar: lookup
  91. Soret R, Chevalier J, De Coppet P, Poupeau G, Derkinderen P, Segain JP. Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. Gastroenterolgoy (2010) 138:1172–82.
    doi: 10.1053/j.gastro.2010.01.053pubmed: 20152836google scholar: lookup
  92. Folwarski M, Dobosz M, Małgorzewicz S, Skonieczna-Zydecka K, Kazmierczak-Siedlecka K. Effects of Lactobacillus rhamnosus GG on early postoperative outcome after pylorus-preserving pancreatoduodenectomy: a randomized trial. Eur Rev Med Pharmacol Sci (2021) 25:397–405.
    doi: 10.26355/eurrev_202101_24407pubmed: 33506929google scholar: lookup
  93. Bajramagic S, Hodzic E, Mulabdic A, Holjan S, Smajlovic SV, Rovcanin A. Usage of probiotics and its clinical significance at surgically treated patients sufferig from colorectal carcinoma. Med Arch (2019) 73:316–20.
  94. Anup R, Aparna V, Pulimood A, Balasubramanian KA. Surgical stress and the small intestine: role of oxygen free radicals. Surgery (1999) 125:560–9.
    doi: 10.1016/S0039-6060(99)70209-6pubmed: 10330946google scholar: lookup
  95. Schneider R, Leven P, Glowka T, Kuzmannov I, Lysson M, Svhneiker B. A novel P2X2-dependent purinergic mechanism of enteric gliosis in intestinal inflammation. EMBO Mol Med (2020) 13:e12724.
    doi: 10.15252/emmm.202012724pmc: PMC7799361pubmed: 33332729google scholar: lookup
  96. Ochoa-Cortes F, Turco F, Linan-Rico A, Soghomonyan S, Whitaker E, Wehner S. Enteric glial cells: a new frontier in neurogastroenterology and clinical target for inflammatory bowel diseases. Inflamm Bowel Dis (2016) 22:433–49.
  97. Stoffels B, Hupa KJ, Snoek SA, van Bree S, Stein K, Schwandt T. POI involves interleukin-1 receptor signaling in enteric glia. Gastroenterology (2014) 146:176–87.
    doi: 10.1053/j.gastro.2013.09.030pubmed: 24067878google scholar: lookup
  98. Al-Sadi R, Ye D, Boivin M, Guo S, Hashimi M, Ereifej L. Interleukin-6 modulation of intestinal epithealial tight junction permeability is mediated by JNK pathway activation of claudin-2 gene. PLoS ONE (2014) 9:e85345.
  99. Savidge TC, Newman P, Pothoulakis C, Ruhl A, Neunlist M, Bourreille A. Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione. Gastroenterology (2007) 132:1344–58.
    doi: 10.1053/j.gastro.2007.01.051pubmed: 17408650google scholar: lookup
  100. Xu DZ, Lu Q, Deitch EA. Nitric oxide directly impairs intestinal barrier function. Shock (2002) 17:139–45.